← All trials
NCT02105766
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 13, 2014
- Primary completion
- Aug 31, 2021
- Completion date
- Aug 31, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 162
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- National Heart, Lung, and Blood Institute (NHLBI)Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)Overall official - principal investigator
- National Cancer Institute (NCI)Collaborator
- National Institutes of Health (NIH)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.